Are weight-loss drugs the reason for Magnum ice cream sales slump?
14 February - 4 mins
Podcast Series
Down To Business
Magnum Ice Cream reported its first full-year results since its December demerger from Unilever, but posted a disappointing 3% drop in sales volumes in the fourth quarter but is it down to the widespread use of GLP-1 drugs? AJ Bell's Investment Director, Russ Mould joins Bobby to discuss.
Series Episodes
